ANDA 78562, held by Rising Pharmaceuticals. Mivacurium Chloride.
As of Nov 21, 2026, ANDA 78562 (Mivacurium Chloride), held by Rising Pharmaceuticals, was first approved by FDA on Apr 30, 2009, with 1 approved supplement and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Apr 30, 2009 | Original application | Approved |
| Product | Active ingredient | Marketing |
|---|---|---|
| Mivacurium ChlorideEQ 2MG BASE/ML · injectable;injection | Mivacurium Chloride | Discontinued |
| Feb 24, 2015 | Supplement 1Labeling | Approved | None posted |
| Apr 30, 2009 | Original application | Approved |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. “What FDA's review says” is read by a model (Claude Haiku) from FDA's summary review PDF; a field is shown only if its numbers appear in the review, and each section links the review. Drugs@FDA and FDA complete response letters